|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| C07K 14/435 | |||
| C07K 16/24 | |||
| C07K 16/28 | |||
| A61P 9/10 |
| (11) | Number of the document | 3261671 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16756389.9 |
| Date of filing the European patent application | 2016-02-25 | |
| (97) | Date of publication of the European application | 2018-01-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/019633 |
| Date | 2016-02-25 |
| (87) | Number | WO 2016/138306 |
| Date | 2016-09-01 |
| (30) | Number | Date | Country code |
| 201562126260 P | 2015-02-27 | US |
| (72) |
LEEPER, Nicholas J., US
WEISSMAN, Irving L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | COMBINATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS |
| COMBINATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS |